Head-To-Head Comparison: Kaya (KAYS) & Its Peers

Kaya (OTCMKTS:KAYSGet Free Report) is one of 992 public companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We will compare Kaya to related companies based on the strength of its earnings, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

Valuation and Earnings

This table compares Kaya and its competitors revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Kaya $200,000.00 $1.61 million -1.75
Kaya Competitors $1.70 billion $149.62 million -3.45

Kaya’s competitors have higher revenue and earnings than Kaya. Kaya is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Volatility & Risk

Kaya has a beta of 0.54, meaning that its share price is 46% less volatile than the S&P 500. Comparatively, Kaya’s competitors have a beta of 1.10, meaning that their average share price is 10% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Kaya and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kaya 0 0 0 0 N/A
Kaya Competitors 6344 18663 44310 912 2.57

As a group, “Pharmaceutical preparations” companies have a potential upside of 77.50%. Given Kaya’s competitors higher probable upside, analysts clearly believe Kaya has less favorable growth aspects than its competitors.

Profitability

This table compares Kaya and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Kaya 821.43% -9.57% 638.26%
Kaya Competitors -2,580.20% -256.50% -30.52%

Institutional & Insider Ownership

44.5% of shares of all “Pharmaceutical preparations” companies are held by institutional investors. 23.5% of Kaya shares are held by company insiders. Comparatively, 14.3% of shares of all “Pharmaceutical preparations” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Kaya Company Profile

(Get Free Report)

Kaya Holdings, Inc., a vertically integrated legal cannabis enterprise, produces, distributes, and/or sells a range of cannabis products primarily in the United States. The company offers flower, oils, vape cartridges and cannabis infused confections, baked goods, and beverages. It also operates retail outlets under the Kaya Shack brand name, as well as offers strain specific cannabis cigarettes under the Kaya Buddies name, and strains of cannabis under the Kaya Farms name. In addition, the company provides standing display cases with cannabis intended glassware under the Really Happy Glass brand; and t-shirt designs under the Kaya Gear brand name. The company was formerly known as Alternative Fuels America, Inc. and changed its name to Kaya Holdings, Inc. in April 2015. Kaya Holdings, Inc. was incorporated in 1993 and is headquartered in Fort Lauderdale, Florida.

Receive News & Ratings for Kaya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kaya and related companies with MarketBeat.com's FREE daily email newsletter.